Gastro-intestinal complement activation during human liver transplantation: Impact on postoperative liver function

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 7, 2000, Pages 850-857

  RØnholm, Ebbe ^a,c   Tomasdottir, H ^a   Runeborg, J ^a   Mattsby Baltzer, I ^b   Olausson, M ^a   Aneman A ^a   Bengtsson, A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Complement; Endotoxin; Gastrointestinal system; Inflammatory mediators; Liver transplantation; Multiple organ failure; Reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENDOTOXIN; PROTHROMBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GRAFT FAILURE; HUMAN; INTENSIVE CARE; LIVER CELL DAMAGE; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DIGESTIVE PHYSIOLOGY; ENDOTOXEMIA; FEMALE; GLYCOPROTEINS; HEPATITIS, TOXIC; HUMANS; LIMULUS TEST; LIVER; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0033943652     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.440711.x     Document Type: Article

References (45)

1. 1. Bion JF, Badger I, Crosby HA, Hutchings P, Kong K-L, Baker J et al. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 1994: 22: 40-49.
2. 2. Függer R, Hamilton G, Steininger R, Mirza D, Schulz F, Mühlbacher F. Intraoperative estimation of endotoxin, TNF-α, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection. Transplantation 1991: 53: 302-306.
3. 3. Rønholm E, Tomasdottir H, Runeborg J, Bengtsson A, Bengtson J-P, Stenqvist O et al. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut. Transplantation 1994: 57: 1594-1597.
4. 4. Spanier TB, Klein RD, Nasraway SA, Rand WM, Rohrer RJ, Freeman RB et al. Multiple organ failure after liver transplantation. Crit Care Med 1995: 23: 466-473.
5. 5. Meakins JL, Marshall JC. The gastrointestinal tract: the "motor" of MOF. Arch Surg 1986: 211: 197-201.
6. 6. Nieuwenhuijzen GAP, Goris RJA. The gut: the "motor" of multiple organ dysfunction syndrome? Curr Opin Crit Care 1999: 5: 126-131.
7. 7. Tomasdottir H, Bengtson JP, Bengtsson A. Neutrophil and macrophage activation and anaphylatoxin formation in orthotopic liver transplantation without the use of veno-venous bypass. Acta Anaesthesiol Scand 1996: 40: 250-255.
8. 8. Kawamoto S, Tashiro S, Miyauchi Y, Inoue M. Mechanism for enterohepatic injury caused by circulatory disturbance of hepatic vessels in the rat. Proc Soc Exp Biol Med 1991: 198: 629-635.
9. 9. Marzi I, Knee J, Menger MD, Harbauer G, Buhren V. Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model. Transplantation 1991: 52: 432-436.
10. 10. Sankary HN, Foster P, Brown E, Williams J. Do splanchnic viscera contribute to liver preservation reperfusion injury? Transplantation 1996: 61: 1142-1147.
11. 11. Steininger R, Roth E, Fugger R, Winkler S, Langle F, Grunberger T et al. Transhepatic metabolism of TNF-alpha, IL-6, and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation 1994: 58: 179-183.
12. 12. Bengtsson A, Redl H, Paul E, Schlag G, Mollnes TE, Davies J. Complement and leukocyte activation in septic baboons. Circ Shock 1993: 39: 83-88.
13. 13. Yokoyama I, Todo S, Miyata T, Selby R, Tzakis AG, Starzl TE. Endotoxemia and human liver transplantation. Transplant Proc 1989: 21: 3833-3841.
14. 14. Yokoyama I, Gavaler JS, Todo S, Miyata T, Van Thiel DH, Starzl TE. Endotoxemia is associated with renal dysfunction in liver transplantation recipients during the first postoperative week. Hepatogastroenterology 1995: 42: 205-208.
15. 15. Hugli TE. Structure and function of the anaphylatoxins. Springer Semin Immunopathol 1984: 7: 193-218.
16. 16. Müller-Eberhard HJ. The membrane attack complex. Springer Semin Immunopathol 1984: 7: 93-141.
17. 17. Poggetti RS, Moore FA, Moore EE, Bensard DD, Anderson BO, Banerjee A. Liver injury is a reversible neutrophil mediated event following gut ischemia. Arch Surg 1992: 127: 175-179.
18. 18. Turnage RH, Guice KS, Oldham KT, Bagnasco J, Weatherbee L. Evidence for a neutrophil-related acute liver injury following intestinal ischemia/reperfusion. Circ Shock 1990: 31: 42.
19. 19. Kolb WP, Müller-Eberhard HJ. The membrane attack mechanism of complement: Isolation and subunit composition of the C5b-9 complex. J Exp Med 1975: 141: 724-735.
20. 20. Podack ER, Kolb WP, Müller-Eberhard HJ. The C5b-6 complex: formation, isolation and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol 1978: 120: 1841-1848.
21. 21. Podack ER, Müller-Eberhard HJ. Isolation from human serum of an inhibitor of the membrane attack complex of complement. J Biol Chem 1979: 254: 9908-9913.
22. 22. Kolb WP, Haxby JA, Arroyave CM, Müller-Eberhard HJ. Molecular analysis of the membrane attack mechanism of complement. J Exp Med 1972: 135: 549-566.
23. 23. Baufreton C, Intrator L, Jansen PG, te Velthuis H, Le Besnerais P, Vonk A et al. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg 1999: 67: 972-977.
24. 24. Bengtsson A, Avail A, Hyllner M, Bengtson JP. Formation of complement split products and proinflammatory cytokines by reinfusion of shed autologous blood. Toxicol Lett 1998: 100-101: 129-133.
25. 25. Kapur MM, Jain P, Gidh M. Estimation of serum complement and its role in management of trauma. World J Surg 1988: 12: 211-216.
26. 26. Conti F, Grude P, Calmus Y, Scoazec JY. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation. J Hepatol 1997: 27: 881-889.
27. 27. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993: 264: G801-G809.
28. 28. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981: 304: 497-503.
29. 29. Bengtson A, Heideman M. Altered anaphylatoxin activity during induced hypoperfusion in acute and elective abdominal aortic surgery. J Trauma 1986: 26: 631-637.
30. 30. Meyer TA, Wang J, Tiao GM, Ogle CK, Fischer JE, Hasselgren PO. Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery 1995: 118: 336-342.
31. 31. Mainous MR, Ertel W, Chaudry IH, Deitch EA. The gut: a cytokine-generating organ in systemic inflammation? Shock 1995: 4: 193-199.
32. 32. Shenkar R, Chang YH, Abraham E. Cytokine expression in Peyer's patches following hemorrhage and resuscitation. Shock 1994: 1: 25-30.
33. 33. Cabie A, Farkas JC, Fitting C, Laurian C, Cormier JM, Carlet J et al. High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine 1993: 5: 448-453.
34. 34. Berg RD. Inhibition of bacterial translocation from the gastrointestinal tract to the mesenteric lymph nodes in specific pathogen-free mice but not gnotobiotic mice by non-specific macrophage activation. Adv Exp Med Biol 1995: 371A: 447-452.
35. 35. Liu DL, Jeppsson B, Hakansson CH, Odselius R. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 1996: 131: 442-447.
36. 36. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore FDJ. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992: 149: 1723-1728.
37. 37. Turnage RH, Bagnasco J, Berger J, Guice KS, Oldham KT, Hinshaw DB. Hepatocellular oxidant stress following intestinal ischemia-reperfusion injury. J Surg Res 1991: 51: 467-471.
38. 38. Jacob AI, Goldberg PK, Bloom N, Degenshein A, Kozinn J. Endotoxin and bacteria in portal blood. Gastroenterology 1977: 72: 1268-1270.
39. 39. Ishii K, Furudera S, Kumashiro R, Koga Y, Hamada T, Sata M et al. Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis. Alcohol Alcohol Suppl 1993: 1B: 97-103.
40. 40. Goto T, Edén S, Nordenstam G, Sundh V, Svanborg-Edén C, Mattsby-Baltzer I. Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol 1994: 1: 684-688.
41. 41. Deitch EA. Bacterial translocation of the gut flora. J Trauma 1990: 30: S184-S189.
42. 42. Le Moine O, Marchant A, Durand F, Ickx B, Pradier O, Belghiti J et al. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 1994: 20: 889-892.
43. 43. Welte M, Pichler B, Groh J, Anthuber M, Jauch KW, Pratschke E et al. Perioperative mucosal pH and splanchnic endotoxin concentration in orthotopic liver transplantation. Br J Anaesth 1996: 76: 90-98.
44. 44. Hamilton G, Prettenhofer M, Zommer A, Hofbauer S, Götzinger P, Gnat FX et al. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. Immunobiology 1991: 182: 425-439.
45. 45. Sautner T, Függer R, Götzinger P, Mittlböck M, Winkler S, Roth E et al. Tumour necrosis factor-α and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation. Eur J Surg 1995: 161: 97-101.